Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1Breast 1

Conditions

Vaping 1Uterine Cervical Dysplasia 1Smoking Cessation 1Cutaneous Squamous Cell Carcinoma 1Breast Neoplasms 1Agnosia 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Transdermal Patch × 90 days × Clear all
NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting
48 enrolled
Dermatologic

Cutaneous Squamous Cell Carcinoma

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

University of Oklahoma

Phase NA Completed
31 enrolled
Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting
123 enrolled
Breast

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡